THE ROLE OF GENETICS IN ALZHEIMER’S DISEASE:
AN EVOLVING LANDSCAPE
A panel of experts discuss the role of genetics in Alzheimer’s disease,
including how genetics is influencing diagnosis and research today.



DATE: Wednesday, March 14, 2012
PLACE: The Times Center
242 W. 41st Street (between 7th & 8th Avenues), New York City


Moderated by WCBS-TV Medical Reporter,
Dr. Max Gomez

Event Participants

• Lou-Ellen Barkan, President & CEO,
  Alzheimer’s Association, New York City Chapter
• Jed Levine, M.A., Executive Vice President,
  Director of Programs and Services,
  Alzheimer’s Association, New York City Chapter
• Richard Mayeux, M.D., M.S., Chairman, Department of Neurology
  and Co-Director, Taub Institute of Research on Alzheimer’s Disease
  and the Aging Brain, Columbia University
• Roy Twyman, M.D., Head of Development, CNS, Neuroscience
  Therapeutic Area, Janssen Research & Development, LLC
• Jennifer Williamson, M.S., M.P.H., Genetic Counselor,
  Taub Institute of Research on Alzheimer’s Disease
  and the Aging Brain, Columbia University

This program was developed by the Alzheimer’s Association, New York City Chapter, Janssen Alzheimer Immunotherapy Research & Development, LLC, Janssen Pharmaceuticals, Inc., and Janssen Research & Development, LLC, with funding from the Janssen companies. This event is for the general public and is not certified for continuing medical education for healthcare professionals.